Journal Article

<i>β</i>‐blockers in left ventricular systolic dysfunction—from evidence to practice

Syamasis Bandyopadhyay and M. Sinead O'Mahony

in Age and Ageing

Published on behalf of British Geriatrics Society

Volume 31, issue 1, pages 23-28
Published in print January 2002 | ISSN: 0002-0729
Published online January 2002 | e-ISSN: 1468-2834 | DOI: http://dx.doi.org/10.1093/ageing/31.1.23
β‐blockers in left ventricular systolic dysfunction—from evidence to practice

Show Summary Details

Preview

Five percent of all hospital medical admissions are patients with heart failure. The incidence is about one new case per 1000 of the general population per year, increasing to >10 per 1000 in those aged ⩾85 years. Although the evidence that β‐blockers reduce mortality by about 36% when added to angiotensin‐converting enzyme inhibitors is overwhelming, clinicians are still reluctant to use β‐blockers in heart failure, especially in older patients. Here, we examine the evidence for the use of β‐blockers in heart failure in older people and explore the practicalities of their use.

Keywords: β‐blockers; heart failure

Journal Article.  0 words. 

Subjects: Geriatric Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.